Log in
OTCMKTS:CNBTF

Cannara Biotech Stock Forecast, Price & News

$0.07
0.00 (0.00 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.07
Now: $0.07▼
$0.07
50-Day Range
$0.04
MA: $0.07▼
$0.13
52-Week Range
$0.08
Now: $0.07▼
$0.20
Volume2,700 shs
Average Volume33,127 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Cannara Biotech Inc.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.50 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry --
Sub-IndustryN/A
Sector--
Current SymbolOTCMKTS:CNBTF
Previous Symbol
CUSIPN/A
CIKN/A
Webcannara.ca
PhoneN/A
Employees13

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
$0.07
0.00 (0.00 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CNBTF News and Ratings via Email

Sign-up to receive the latest news and ratings for CNBTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cannara Biotech (OTCMKTS:CNBTF) Frequently Asked Questions

What stocks does MarketBeat like better than Cannara Biotech?

Wall Street analysts have given Cannara Biotech a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cannara Biotech wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Cannara Biotech's key competitors?

Some companies that are related to Cannara Biotech include 378 (SCCB), ACE Convergence Acquisition (ACEVU), AEA-Bridges Impact (IMPXU), AllianzGI Artificial Intelligence Opportunities Fund (AIO), Altimeter Growth (AGCUU), ArcLight Clean Transition (ACTCU), Atlas Crest Investment (ACICU), Avanti Acquisition (AVANU), Blackstone / GSO Floating Rate Enhanced Income Fund (BGFVX), Blackstone / GSO Floating Rate Enhanced Income Fund (BGFPX), Bluescape Opportunities Acquisition (BOACU), Burgundy Technology Acquisition (BTAQU), CIM Real Assets & Credit Fund (ARACX), CIM Real Assets & Credit Fund (IRACX) and CIM Real Assets & Credit Fund (LRACX).
View all competitors.

Who are Cannara Biotech's key executives?

Cannara Biotech's management team includes the following people:
  • Mr. Zohar Krivorot, Founder, Pres, CEO & Director (Age 42)
  • Mr. Lennie Ryer CPA, CPA, CA, CFE, VP of Fin. & CFO (Age 58)
  • Mr. Evan Morris, Chief Operating Officer
  • Ms. Julia Bouvet, Chief of Staff

What is Cannara Biotech's stock symbol?

Cannara Biotech trades on the OTCMKTS under the ticker symbol "CNBTF."

How do I buy shares of Cannara Biotech?

Shares of CNBTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cannara Biotech's stock price today?

One share of CNBTF stock can currently be purchased for approximately $0.07.

What is Cannara Biotech's official website?

The official website for Cannara Biotech is cannara.ca.

This page was last updated on 11/26/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.